Novocell Announces Discovery Linking Key Cancer Cell Signaling Pathways With Proliferation And Self Renewal Of Human Embryonic Stem Cells
Aug 31st 2007Drug InformationCancer
Novocell Inc., a stem cell engineering company, announced research findings that for the first time identify two prominent cancer cell signaling pathways as essential for the efficient proliferation and self-renewal of human embryonic stem cells (hESCs). The findings were prepublished online August 29, 2007 in Blood First Edition Paper titled “Self-Renewal of Human Embryonic Stem Cells Requires Insulin-like Growth Factor-1 Receptor and ERBB2 Receptor Signaling. [click link for full article]
More: continued here
No Comments »
Leave a Reply
You must be logged in to post a comment.
